Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $39.6200 (-4.62%) ($39.6200 - $41.3900) on Thu. May. 6, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.41% (three month average) | RSI | 38 | Latest Price | $39.6200(-4.62%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX declines -1.6% a day on average for past five trading days. | Weekly Trend | TGTX declines -0.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(68%) ARKG(63%) ARKK(58%) IBB(58%) IWO(58%) | Factors Impacting TGTX price | TGTX will decline at least -1.705% in a week (0% probabilities). VIXM(-42%) VXX(-36%) UUP(-18%) UNG(-3%) TLT(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.705% (StdDev 3.41%) | Hourly BBV | -1.1 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $34.28(-13.48%) | Resistance Level | $42.98 | 5 Day Moving Average | $41.99(-5.64%) | 10 Day Moving Average | $42.59(-6.97%) | 20 Day Moving Average | $42.98(-7.82%) | To recent high | -24.4% | To recent low | 0% | Market Cap | $5.018b | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |